Number of the records: 1  

Deoxynojirimycin and its hexosaminyl derivatives bind to natural killer cell receptors rNKR-P1A and hCD69

  1. 1.
    SYSNO ASEP0348116
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleDeoxynojirimycin and its hexosaminyl derivatives bind to natural killer cell receptors rNKR-P1A and hCD69
    Author(s) Catelani, G. (IT)
    D’Andrea, F. (IT)
    Griselli, A. (IT)
    Guazelli, L. (IT)
    Němcová, P. (CZ)
    Bezouška, K. (CZ)
    Křenek, Karel (MBU-M)
    Křen, Vladimír (MBU-M) RID, ORCID
    Source TitleBioorganic and Medicinal Chemistry Letters. - : Elsevier - ISSN 0960-894X
    Roč. 20, č. 15 (2010), s. 4645-4648
    Number of pages4 s.
    Languageeng - English
    CountryGB - United Kingdom
    KeywordsDeoxynojirimycin ; NK cells ; hCD69 receptors
    Subject RIVCC - Organic Chemistry
    R&D ProjectsOC 136 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    LC06010 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    CEZAV0Z50200510 - MBU-M (2005-2011)
    UT WOS000279866300079
    DOI10.1016/j.bmcl.2010.05.109
    AnnotationDeoxynojirimycin (1) and two new related 4-O-hexosaminyl-containing disaccharide mimics, Beta-D-Tal-NAc-(1-4)-DNJ (4) and Beta-D-ManNAc-(1-4)-DNJ (5), have been studied as agonists of natural killer (NK) cell receptors. As a positive and unexpected result, DNJ (1) displayed a remarkable activation effect towards both NKR-P1A (rat) and CD69 (human) receptors, and a quite similar activity was found for 4 and 5. The synthesis of the two disaccharide mimics is based on an approach that avoids the glycosylation step using known intermediates arising from lactose. The key stage of the synthesis involves the construction of the DNJ unit through an initial C-5 oxidation of the reducing D-glucopyranosyl unit followed by a stereoselective double-reductive aminocyclization of the 1,5-dicarbonyl disacharide intermediates
    WorkplaceInstitute of Microbiology
    ContactEliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231
    Year of Publishing2011
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.